<DOC>
	<DOCNO>NCT00221143</DOCNO>
	<brief_summary>The purpose study determine stem cell therapy one 's cell ( autologous cell ) deliver intramuscularly one 's leg ulcer and/or gangrene due poor blood flow safe relieve leg pain , increase blood flow , and/or cure leg wound .</brief_summary>
	<brief_title>Stem Cell Study Patients With Leg Ulcer/Gangrene</brief_title>
	<detailed_description>Chronic critical limb ischemia ( CLI ) progressive disease , arise result atherosclerosis vasculitis leg artery . Prognosis chronic CLI poor , effective treatment establish patient eligible traditional revascularization therapy angioplasty bypass procedure due inappropriate anatomy leg arteries frequent reocclusion follow revascularization . Therefore , necessary establish novel revascularization treatment improve prognosis no-option patient . We study safety clinical efficiency vascular regeneration mean transplantation autologous peripheral blood endothelial progenitor cell ( CD34 positive cell ) patient chronic CLI eligible traditional revascularization treatment . The primary endpoint primary efficacy score identify toe brachial blood pressure index ( TBPI ) , absolute claudication distance ( ACD ) Wong Baker 's pain rating scale , secondary endpoint evaluation safety , ankle brachial blood pressure index ( ABPI ) , percutaneous tissue oxygen pressure ( TcPO2 ) , etc .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Gangrene</mesh_term>
	<criteria>Chronic severe CLI patient fulfil follow criterion consider suitable inclusion study . 1 . At least 6 month since onset CLI ( Chronic peripheral artery disease Buerger disease ) 2 . Patients luminal stenosis &gt; 50 % leg angiography 3 . Age 20 80 . 4 . Patients whose Rutherford 's class II4 , III5 , III6（Patients rest pain ischemic ulcer/necrosis ) 5 . Patients angioplasty bypass surgery indicate anatomical procedural reason frequent reocclusion/ restenosis follow traditional revascularization ( No option patient ) 6 . Patients give informed consent write . Any one follow exclusion criterion sufficient disqualify patient study . 1 . Left ventricular ejection fraction &lt; 25 % 2 . Patients history severe allergic reaction side effect GCSF preparation apheresis . 3 . Less 6 month since last episode myocardial/cerebral infarction . 4 . Patients unstable angina , treatment rating 3 Braunwald system , severity III clinical rating B C. 5 . Patients diabetic proliferate retinopathy ( new Fukuda classification BI BV ) . 6 . Patients malignant tumor 7 . Patients chronic rheumatoid arthritis . 8 . Patients hematological disease ( leukemia , myeloproliferative disease , myelodysplastic syndrome ) . 9 . Patients currently suffer history interstitial pneumonitis . 10 . Patients cranial MRA reveal cerebral aneurysm . 11 . Patients abdominal CT ultrasonography reveals splenomegaly . 12 . Patients cirrhosis liver . 13 . Patients discontinue Warfarin . 14 . Leukocytes less 4,000/µL exceed 10,000/µL . 15 . Platelets le 100,000/µL . 16 . Hemoglobin le 10 g/dL . 17 . AST ( GOT ) exceed 100 IU/L ALT ( GPT ) exceed 100 IU/L . 18 . Patients severe neural disorder leg . 19 . Patients gait disturbance reason CLI ( sciatic neuralgia , vasculitis ) , make exercise tolerance evaluation treadmill stress ECG difficult . 20 . Pregnant nursing patient , may pregnant , plan become pregnant end study period . 21 . Any reason Clinical Supervisors Clinical Researchers may consider case unsuitable study .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Ulcer/ gangrene</keyword>
	<keyword>Leg disease</keyword>
	<keyword>Pain</keyword>
	<keyword>Vascular disease</keyword>
	<keyword>Chronic limb ischemia</keyword>
	<keyword>Peripheral artery disease</keyword>
</DOC>